The Valley Desk

Clinical trial reportRMD openPublished

Nipocalimab and certolizumab combination therapy in participants with active rheumatoid arthritis despite prior treatment with advanced therapies: results from the phase 2a DAISY-RA study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
RMD open
Published
Subject terms
Humans; Arthritis, Rheumatoid; Antirheumatic Agents; Treatment Outcome; Drug Therapy, Combination; Adult; Aged; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized; Certolizumab Pegol
PubMed ID
41781163
PubMed Central ID
PMC13266242
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal